Member Info for JustHereForHemo

TBH think its just complacency and habit, Whoever it was has seen every time Hemo has a good RNS update and spiked if you wait for volume to die and short they can push it down, apathy kicks in, traders move on, SP falls and bank 5-10%.

People calling that the Response must have been sent last week? So the FDA have had it for a week? I wonder how long it takes to look at results from ONE PQ, will they re-read the previously submitted exit from CH plan? Who knows....

FDA could lift CH tomorrow or they could take another few weeks, it is indeed russian roulette to try and trade it.

For those who say "So what, its only an IND, SP wont move", lol, time will tell. If you can find a comparable company with CAR-T in clinical trials for CAR-T, 100% owned at anything even remotely close to 25m then please share! There was not alot of PR around the submission and yet we still had excellent volume, expect ALOT more PR and coverage when Hemogenyx actually go clinical. Sleep tight anyone who is short, tick tock!

Brad sounds nice, I like Brad :-)

I am not sure it will go exactly like that, but why not? Its not a full review, the changes made have already been approved and signed off, whats missing is the test results and third party certification. The FDA dont re-test themselves they trust what they are sent, why would it take 30 days when they did the whole review in 30 days???

OR maybe it goes into an intray and gets picked up in the order it is received and wont even be looked at for 2 weeks. 1 day-> 30 days that is the realistic range, NONE of us know, not even the traders/shorters. If people want to gamble and hold their shorts open? Be my guest, I sleep easy at night!

Anyone shorting is not stupid, they know going clinical is a big deal and does lead to a rerate. It's not speculation or ramping, the PR and coverage that will follow CH will push this up, to where? God knows.

Sp went up yesterday, shorters took advantage and opened more when it was like 10% up and knocked it down.

OFCOURSE they will try and close before the FDA respond. Just remember this is with the FDA. Vlad might be incapable of moving in second gear but it's with the FDA not him. It's a pure and utter gamble to be short right now and every day that passes is a huge risk of getting caught out.

So again tick tock :-D sleep tight traders

Tick tock :-D

We certainly are attracting them today! Must be having twitchy bottoms knowing the FDA could literally respond at any time. Could be weeks.... but likewise could be days.

FDA raised ONE issue

FDA approved plan to lift the CH

Hemo have done what they agreed and have responded to the FDA. I wonder when Hemo sent the response and how long it will take to review one set of results....

Tick tock lol

CAR-T licencing deals in recent years easy to find, $47m might be average for all pharma licencing deals but not CAR-T where you are talking probably 300-1b+ in up front/milestones/biobucks, eg:

https://bioprocessintl.com/bioprocess-insider/deal-making/legend-and-novartis-sign-100m-car-t-license-agreement

HOWEVER.

Remember HEMO-CAR-T is just the booster rocket to get Hemo off the launch pad, the funding and recognition as clinical that attracts unlocks CBR and CDX which have been somewhat stagnated due to lack of time and money resources. CBR is the main payload, CAR-T is just the first, easy to understand and value piece of the puzzle.

God I am starting to love you Haywain, you are such a huge asset to this board :-)

Final tally - Running out of dates and busy day ahead!

17th - Bobbyjack09

19th - Drutor (Predicts open 5p!)

22nd - JHFH, dingodomingo

23rd - subush79

24th - Orhyblue

25th - Trift8082

26th - Charles175, B311apad

29th - dhub, Idiot

30th - Moorscloud, NCTrade (Yes I remember, but cant remember who maintained it)

31st - PK1

1st - Hedge

2nd - Tillywhiz

5th - Blastoid7

6th - Brendy23

7th - Chris0123, ribbit2

8th - Saint68

9th - MrJinx

10th - Cyrox

Never - simonthezealot (They have 30 days so 23rd not valid)

Hemo picked a particularly nasty form of AML with few options and only around 500 diagnosed each year in the US as suggested by the FDA due to lack of other companies targeting this disease. Yes there are other CAR-T treatments for various blood cancers in the pipeline, but there is room in the market for many, people relapse and need to switch treatments (there are multiple targets, Hemo I think are targeting FLT3?). Fact is right now the big players dont want to focus research on the slice of the pie Hemo are targeting, but for a company as small as Hemo it is a HUGE oppertunity.

17th - Bobbyjack09

19th - Drutor (Predicts open 5p!)

22nd - JHFH, dingodomingo

23rd - subush79

24th - Orhyblue

25th - Trift8082

26th - Charles175

29th - dhub

30th - Moorscloud, NCTrade (Yes I remember, but cant remember who maintained it)

31st - PK1

1st - Hedge

2nd - Tillywhiz

5th - Blastoid7

6th - Brendy23

7th - Chris0123

8th - Saint68

9th - MrJinx

Never - simonthezealot (They have 30 days so 23rd not valid)

Chris, honestly IMO anyone who thinks this is a good share to trade is bonkers, you know me, I like to research, I have read everything from hemo and any document I can find RE CH from the FDA. My conclusions? The could lift the CH tomorrow, or they could take the full 30 days, or any single day in between. I think sooner rather than later but thats a guess. This is with the FDA, there will be no leaks, it will happen when it happens and if traders want to try and predict? They have as much chance as the rest of us so good luck!

So far we have:

17th - Bobbyjack09

22nd - JHFH, dingodomingo

23rd - subush79

24th - Orhyblue

25th - Trift8082

29th - dhub

30th - Moorscloud

31st - PK1

1st - Hedge

2nd - Tillywhiz

5th - Blastoid7

7th - Chris0123

8th - Saint68

9th - MrJinx

Good luck punters, markers at the ready!

So far we have:

22nd - JHFH, dingodomingo

23rd - subush79

25th - Trift8082

29th - dhub

30th - Moorscloud

1st - Hedge

Good luck punters, markers at the ready!

OK bit of fun, 29 days until deadline. Exclude the weekends, let's see who gets closest to CH lift "RNS". I'm taking 22nd Jan. Personally I can see FDA reviewing it in a few days if its literally one section +test results.

Winner gets bragging rights.

Worth noting Hulver that Hemogenyx are main market, as such vlad cannot do any sort of placing premium or otherwise until early February at the earliest AND can only issue like 20% dilution. So to pay for trials Vlad will need mCap to be either somewhere up near 100m OR find some non dilutitive funding. 1 or 2 million in a discount placing is NOT GOING TO HAPPEN. Its useless, they are going to need 5-10mil MINIMUM.

I point this our as we are now seeing on twitter the attack vector from the trolls/shorters is placing. Predictable but pathetic, given its impossible due to the 20% rule. They have good reason to be nervous:-)

Ñttg irrespective of when vlad sent the response the fact is the FDA have already done a full review and found one issue. They were sent a proposal to lift the CH and accepted it, requiring one PQ run as validation. If they were able to do a full review in 30 days is it really going to take 30 days to validate hemo have done exactly what they said they would and review the results from one PQ? Haywain gave 2 weeks from his personal experience, imo that sounds extremely reasonable.

Jinx, oilers and miners are the same they go through the roof, pump, rns, interviews, tweets and videos all leading up to a massive placing which is needed to fund the next stage. Its a coordinated operation with paid pumpers, brokers etc designed to make PIs think THIS TIME is the one that will make them rich, then discount placing, rinse and repeat.

Hemo? Yes they need cash to pay for trials, they will Probably do another premium subscription with Prevail again. However this is where pharma is different to miners and oilers, we are here for licencing, miners are here for "production" or grades, or offloaded results etc. Basically put in a few million hoping to get back and sell a few more million in product in a poorly kept secret. Hemo? Behind closed doors at some point, probably very soon, Vlad will sign a licencing deal with a big pharma, Joe the truck driver won't see it, sandy the assistant at the lab testing for lithium purity won't know about it but one day vlad will sign a licencing deal. Few mil input and over night he will sell CAR-T for 100s of millions, maybe a bn in bio bucks, who knows.

Clinical oncology pharam with car-t just are not 25mil companies, 100m-300m is the lower range (excluding CBR). Today was lackluster, there was very little coverage, but let's be clear, this IS an unsustainable SP, Hemogenyx will be clinical soon, things here will change very soon. Don't make the mistake of thinking hemo is like an oiler or miner, small pharma can and do hit 1000% in a day on the right updates and going clinical at 25m could very well be one of those updates.

Fully agree Dog, Haywain is a godsend to this board. NOBODY can accuse him of ramping, if anything he is usually more of a damp cloth.... however THIS is his job, he knows the science, knows the processes and knows how to read between the lines and can fill in the huge voids left by vlads RNSs. I am one of the many who takes enormous comfort from his posts :-)

Excellent Haywain, I tried to find average response timr for FDA, your example of 2 weeks would be absolutely fantastic, clinical by end of the month!

I would absolutely love IND approval before end of month, it would land when Vlad CANNOT do a placing, peterhouse won't be able to ply vlad with offers of cash on behalf of shorting traders and we might actually see a significant rerate that holds!

Hemo have form for this, disappointing rns day then much better in following days. Very little press coverage of the rns, there was 100 times more when the clinical hold was applied, they better cover it aswell when hold is officially lifted!

Anyone want to admit selling today, banking 5% and hoping to get back in cheaper? If so are you one of those convinced hemo still needed third party tests and believed IND was months away? In that case good luck! 30 day max but imo much sooner!

In a recent leaked video Vlad was doing a presentation on CBR where he revealed it appears to work on brain cancer amongst other hard to understand and hear details. What was most exciting in that video however was what happened at the end....

This was a presentation about CBR and ONLY CBR, at the end a representative of Prevail stood up and invited anyone who was interested and wanted to invest in CBR to come and speak to her about it. So Prevail are 100% involved to a higher level than just CAR-T :-)

Per FDA: 30-day Response Clock: The FDA is required by the Modernization Act to respond in writing to the

applicant within 30 calendar days after receipt of the applicant's complete response to a clinical hold (§

312.42(e)). - So MAX 30 days for Clinical hold to be lifted, its extremely likely to be lifted as the submission has already been accepted by the FDA and just needed test results. So 30 days is a MAXIMUM, Fully expect less.

THEN once hold lifted expect:

Announcement of start of Clinical Trials to be managed by Prevail - Who are excellent for managing market updates

Cash injection from Prevail + others

Outside of CAR-T:

Vlad is now FINISHED with the IND, its gone, he is now free to focus on CBR and CDX, it was made clear that AFTER IND CBR would ramp up, so expect to see a greater news flow regarding other pipelines.

PROBABLY going to see website update and updated brokers note once Hemogenyx are CLINICAL

Fundamentally for the last few years Vlad has made it clear, IND is ALL. Getting Hemogenyx into clinical trials is the first priority, everything else was a background task, progress was made but slow. Today is the beginning of the end of the pre-clinical Hemogenyx, needless to say I am very very excited!!!